Drug Policies and Development

Julia Buxton is the British Academy Global Professor in Criminology at the University of Manchester, UK and a Senior Research Associate at the Global Drug Policy Observatory, Swansea University, UK.Mary Chinery-Hesse is the first woman Chancellor of the University of Ghana and a member of the West Africa Commission on Drugs. She was UNDP Resident Representative, Deputy Director-General of the ILO, and Chief Advisor to the President of the Republic of Ghana. Khalid Tinasti is the Executive Secretary of the Global Commission on Drug Policy and a Research and Teaching Fellow at the Global Studies Institute at the University of Geneva. He focuses on public policies, democracy, elections, and international drug control.

"In the era of sustainable development, cross-cutting issues such as drug control—with real-life impacts on public health, public security and the enjoyment of human rights—need to be aligned with the priorities of achieving the 2030 Agenda. This volume by International Development Policy and the Global Commission on Drug Policy provides an insight into the political, economic and social barriers to needed drug policy reforms."— Helen Clark, former Administrator of UNDP; member of the Global Commission on Drug Policy"With a complex architecture, multi-stakeholder involvement, and multi-sector intervention, drug policy remains a neglected area in public policy analysis, while it engages massive resources and directly impacts development indicators. This volume of International Development Policy provides the reader with a structured path via which to capture the challenges that drug policy poses, and how they translate as barriers to development on the ground."— Mohammad-Mahmoud Ould Mohamedou, Professor of International History, the Graduate Institute

• ForewordPrefaceList of IllustrationsList of Acronyms and AbbreviationsNotes on ContributorsIntroduction1 Are Barriers to Sustainable Development Endogenous to Drug Control Policies?Khalid Tinasti, Julia Buxton and Mary Chinery-HessePART 1Milestones of Drug Policies and Development2 Drug Control and Development: a Blind SpotJulia Buxton3 Imperial Drug Economies, Development, and the Search for Alternatives in Asia, from Colonialism to DecolonisationJohn Collins4 From Alternative Development to Development-oriented Drug PoliciesDaniel Brombacher and Sarah David5 Trying to Be All Things to All People: Alternative Development in AfghanistanDavid Mansfield6 Cannabis Regulation and Development: Fair(er) Trade Options for Emerging Legal MarketsDavid Bewley-Taylor, Martin Jelsma and Sylvia KayPART 2Human Development and Drug Policies7 Making War: Conflict Zones and Their Implications for Drug PolicyTuesday Reitano8 The Neo-patrimonial ‘Use’ of Drug Policy in Electoral ProcessesKhalid Tinasti9 The Meaningful Participation of ‘Stakeholders’ in Global Drug Policy Debates—A Policy CommentAnn Fordham10 The World Drug Policy Problem: Interview with José Ramos-HortaJosé Ramos-Horta and Khalid TinastiPART 3Drugs, Development and Cross-cutting Issues11 The Rif and California: Environmental Violence in the Era of New Cannabis MarketsKenza Afsahi12 The Gendered Impacts of Drug Policy on Women: Case Studies from MexicoCorina Giacomello13 Incorporating Child Rights into Scheduling Decisions at the UN Commission on Narcotic DrugsDamon Barrett and Diederik Lohman14 More Harm than Public Health in Drug Policy? A CommentJoanne Csete15 Prohibitionist Drug Policy in South Africa—Reasons and EffectsAndrew Scheibe, Shaun Shelly and Anna VersfeldIndex